Long-term endoscopic remission in Crohn’s disease after allogeneic hematopoietic stem cell transplantation for diffuse large B cell lymphoma: case report and literature review-Reference-Cited by-同舟云学术

Long-term endoscopic remission in Crohn’s disease after allogeneic hematopoietic stem cell transplantation for diffuse large B cell lymphoma: case report and literature review

Published:2021-03-30 Issue: Volume: Page:
ISSN:1865-7257
Container-title:Clinical Journal of Gastroenterology
language:en
Short-container-title:Clin J Gastroenterol

Author:

Inomata Yushi^ORCID,Kuroha Masatake,Handa Tomoyuki,Shimoyama Yusuke,Moroi Rintaro,Shiga Hisashi,Kakuta Yoichi,Ichikawa Satoshi,Fukuhara Noriko,Sato Yuichiro,Takahashi Taro,Masamune Atsushi

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12328-021-01389-4.pdf

Reference18 articles.

1. Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology. 2007;133:1670–89.

2. Drakos PE, Nagler A, Or R. Case of Crohn’s disease in bone marrow transplantation. Am J Hematol. 1993;43:157–8.

3. Hawkey CJ, Allez M, Clark MM, et al. Autologous hematopoetic stem cell transplantation for refractory Crohn disease: a randomized clinical trial. JAMA. 2015;314:2524–34.

4. Oliveira MC, Elias JB, Moraes DA, et al. A review of hematopoietic stem cell transplantation for autoimmune diseases: multiple sclerosis, systemic sclerosis and Crohn’s disease. Position paper of the Brazilian Society of Bone Marrow Transplantation. Hematol Transfus Cell Ther. 2021;43:65–86.

5. Snowden JA, Hawkey C, Hind D, et al. Autologous stem cell transplantation in refractory Crohn’s disease—low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study. BMC Gastroenterol. 2019;19:82.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can allogeneic haematopoietic cell transplantation be curative in classical Crohn's disease?;British Journal of Haematology;2022-11-09

2. Adalimumab/infliximab;Reactions Weekly;2021-09